KIMBERLY MORRIS: Open Payments
NPI 1801285523 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $205 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. | 1 | $102 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Genmab U.S., Inc. | 1 | $16 |
Products named: Columvi, ERLEADA, KISQALI, PLUVICTO, ULTOMIRIS, Venclexta, CABOMETYX, ELREXFIO.
Industry payments across AL — which companies pay providers there.
